Enhanced Hematological Recovery, But A High Incidence Of Grade (Gd) Iii/Iv Toxicities, Attributed To Interleukin-6 (Il-6) In Children With Recurrent/Refractory Solid Tumors Treated With Il-6 And G-Csf Following Ifosfamide, Carboplatin, And Etoposide (Ice).